A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer
Status:
Completed
Trial end date:
2019-05-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of JNJ-56021927 in
Japanese participants with metastatic castration-resistant prostate cancer (mCRPC- prostate
cancer that is resistant to medical [for example. hormonal] or surgical treatments).